当前位置: 首页 > 学术作品
O²-3-Aminopropyl diazeniumdiolates suppress the progression of highly metastatic triple-negative breast cancer by inhibition of microvesicle formation via nitric oxide-based epigenetic regulation
时间:2018-09-05 13:07:00
作品信息

期刊

Chemical Science

标题

O²-3-Aminopropyl diazeniumdiolates suppress the progression of highly metastatic triple-negative breast cancer by inhibition of microvesicle formation via nitric oxide-based epigenetic regulation

作者

Fenghua Kang, Jiayi Zhu, Jianbing Wu, Tian Lv, Hua Xiang, Jide Tian, Yihua Zhang, Zhangjian Huang

摘要

Currently, there is no effective therapy for the treatment of highly metastatic triple-negative breast cancer (TNBC). Microvesicle (MV) formation is crucial for the metastasis of TNBC. Here we report a novel strategy to inhibit the generation of MVs for the intervention of TNBC. O2-3-Aminopropyl diazeniumdiolates 3a–f are designed and synthesized, which can be activated by lysyloxidase over-expressed in TNBC cells. The most active compound 3f is able to selectively release high levels of NO in TNBC cells, inhibit the cell proliferation, and reduce the adhesion, invasion and migration of TNBC cells in vitro. Furthermore, 3f significantly suppresses the growth and metastasis of implanted TNBC in vivo through attenuating MV formation by an epigenetic modification of miR-203/RAB22A expression in an NO-dependent manner, providing the first evidence of NO donor(s) acting as epigenetic modulators to fight highly metastatic TNBC.

原文链接

http://pubs.rsc.org/en/content/articlelanding/2018/sc/c8sc00167g#!divAbstract

在线咨询
ONLINE CONSULTING
电话咨询
PHONE CONSULTING

010-82449939